Home » Topics » Regulatory, BioWorld Science

Regulatory, BioWorld Science
RSS

Spanish AEMPS approves CAR-T ARI-0001 for ALL

Feb. 12, 2021

FDA approves Evkeeza for homozygous familial hypercholesterolemia

Feb. 12, 2021

FDA grants EUA for etesevimab and bamlanivimab for mild to moderate COVID-19

Feb. 10, 2021

FDA approves Libtayo for advanced basal cell carcinoma

Feb. 10, 2021

FDA approves Breyanzi for relapsed or refractory large B-cell lymphoma

Feb. 8, 2021

FDA grants accelerated approvals of Ukoniq for marginal zone lymphoma and follicular lymphoma

Feb. 8, 2021

Korean MFDS grants conditional marketing authorization for Regkirona for COVID-19

Feb. 8, 2021

FDA grants accelerated approval to Tepmetko for metastatic NSCLC with METex14 skipping alterations

Feb. 4, 2021

E.U. grants conditional marketing authorization to AstraZeneca COVID-19 vaccine

Feb. 1, 2021

Rinvoq approved in E.U. for psoriatic arthritis and ankylosing spondylitis

Jan. 26, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...